M&T Bank Corp Argenx Se Transaction History

M&T Bank Corp

$139 Billion
Q3 2024

A detailed history of M&T Bank Corp transactions in Argenx Se stock. As of the latest transaction made, M&T Bank Corp holds 4,307 shares of ARGX stock, worth $2.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,307

Previous 4,018 7.19%

Holding current value

$2.43 Million

Previous $1.73 Million 35.21%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$434.22 - $551.9 $125,489 - $159,499	289 Added 7.19%	4,307 $2.34 Million
Q2 2024 Jul 31, 2024	BUY	$356.01 - $451.55 $359,926 - $456,517	1,011 Added 33.62%	4,018 $1.73 Million
Q1 2024 May 07, 2024	BUY	$356.95 - $413.29 $36,051 - $41,742	101 Added 3.48%	3,007 $1.18 Million
Q4 2023 Feb 06, 2024	SELL	$338.91 - $506.01 $53,547 - $79,949	-158 Reduced 5.16%	2,906 $1.11 Million
Q3 2023 Nov 02, 2023	SELL	$369.35 - $548.43 $31,764 - $47,164	-86 Reduced 2.73%	3,064 $1.51 Million
Q2 2023 Aug 09, 2023	BUY	$360.14 - $422.58 $6,842 - $8,029	19 Added 0.61%	3,150 $1.23 Million
Q1 2023 May 11, 2023	BUY	$334.23 - $403.65 $1.05 Million - $1.26 Million	3,131 New	3,131 $1.17 Million
Q3 2021 Oct 28, 2021	SELL	$295.0 - $350.58 $209,745 - $249,262	-711 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$257.11 - $319.92 $90,245 - $112,291	-351 Reduced 33.05%	711 $214,000
Q1 2021 May 06, 2021	SELL	$268.3 - $380.31 $12,878 - $18,254	-48 Reduced 4.32%	1,062 $293,000
Q4 2020 Feb 12, 2021	BUY	$248.13 - $308.36 $21,091 - $26,210	85 Added 8.29%	1,110 $327,000
Q3 2020 Nov 06, 2020	SELL	$215.51 - $272.51 $94,177 - $119,086	-437 Reduced 29.89%	1,025 $269,000
Q2 2020 Jul 29, 2020	BUY	$127.44 - $232.72 $186,317 - $340,236	1,462 New	1,462 $330,000
Q1 2020 May 14, 2020	SELL	$108.83 - $165.23 $150,511 - $228,513	-1,383 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$106.59 - $164.21 $147,413 - $227,102	1,383 New	1,383 $222,000

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account